Mild or moderate hypoglycemia occurred in 31% of repaglinide tablets treated patients and 7% of placebo treated patients [see Warnings and Precautions (5.1])
Consider NAC, MSM, or glutathione if sulfur is low
Surprisingly, allulose levels increased steadily over a 90-min period, independent of the health status, while glucose levels displayed characteristic profiles with a peak at about 3060 min (Reference Mack, Ferrario and Weinert5)
The percentage of patients who discontinued due to ineffective therapy was 0.9% in the liraglutide injection 1.8 mg + metformin + glimepiride treatment group, 0.4% in the insulin glargine + metformin + glimepiride treatment group, and 11.3% in the placebo + metformin + glimepiride treatment group
Repeat IGF-1
Every batch of Koi GLP-2 (Triz) is synthesized and lyophilized in the United States, then released against independent third-party laboratory (Freedom Diagnostics Testing) testing